Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
News News tary interventions, including genetically engineered foods that block or delay the onset of malignancy. Also, genetic testing will usher in the ability to identify people at especiallv hieh or low risk of cancer — an advance that carries both the enormous potential to improve human health and the risk of abuse. Those at low risk for 'f y f i cancer may be *' spared rempeated and Dr. Arnold Levlne costly screenings, while those at high risk may be monitored closely enough that nontoxic preventive agents can stop incipient cancers from ever developing. However, high-risk individuals may also suffer genetic discrimination unless legal and ethical safeguards are firmly in place. Challenges The good news about cancer during the next quarter-century is also tempered by other obstacles looming in the future, including funding threats to the cancer effort and the difficulty of applying the benefits of the National Cancer Program to everyone. If these challenges are not met, experts say, the scientific advances of the past 25 years will not be translated into large, measurable gains against cancer incidence and mortality in the U.S. population. In spite of the wealth of new knowledge generated since 1971, support for basic research needs to continue, observers say. "We owe an enormous debt in cancer research to fundamental yeast genetics and analysis of the cell cycle," 1796 NEWS After the Act: 25 Years of Advances Against Cancer The past quarter-century has seen remarkable advances against cancer, many coming as a direct or indirect result of passage of the National Cancer Act in 1971. Among them: Cancer Mortality Rates: • Overall cancer death rates fell 2.6% from 1991 to 1995 • Lung cancer death rates for men fell 6.7% from 1991 to 1995 • Death rate for colorectal cancer dropped 17% since 1973 • Death rate for breast cancer dropped 7.7% from 1989 to 1995 • Testicular cancer death rate dropped 66% since 1973 • Hodgkin's disease death rate dropped 57% since 1973 • Death rate for childhood leukemia is down 52% since 1973 Technologies: • Recombinant techniques developed for cloning genes, mid-1970s • Hybridoma technology for monoclonal antibodies developed, 1975 • Southern blot technique to identify DNA fragments developed, 1975 • Methods developed to sequence DNA fragments, 1975 to 1976 • First biotechnology firm (Genentech) founded, 1976 • Restriction fragment length polymorphism technique used in cancer, 1983 • Polymerase chain reaction technique developed, mid-1980s • Severe combined immunodeficiency (SOD) mice developed, mid-1980s • Fluorescence in situ hybridization (FISH) technique developed, about 1990 Cancer Genetics: • First (src) of some 50 now-known human proto-oncogenes discovered, 1976 • Most frequently mutated gene in human cancer, p53, discovered, 1979 • First (RB1) of some 20 now-known tumor suppressor genes cloned, 1986 • First human gene therapy for cancer (melanoma), 1991 • First (hMSH2) of the hereditary nonpolyposis colon cancer genes cloned, 1993 • BRCA1 and BRCA2 inherited breast cancer genes cloned, 1994 and 1995 Epidemiology: • Surveillance, Epidemiology, and End Results (SEER) Program established, 1973 • Development of logistic regression statistics for multiple variables • Integration of biochemical assays into epidemiologic studies (molecular epidemiology) Treatment: • Interleukin-2 discovered, 1976 • First human testing of a biological therapy (oc-interferon), 1978 • Adjuvant therapies shown to improve disease-free survival in early breast cancer, 1978 • First human cancer vaccine (hepatitis B virus vaccine, for liver cancer), 1981 • Community Clinical Oncology Program established, 1983 • Breast-sparing surgery replaced Halsted radical mastectomy for breast cancer, 1985 • Modified prostatectomy to preserve potency developed, 1986 • Adjuvant chemotherapy found to increase survival in colon cancer, 1989 • Adjuvant radiation and chemotherapy found to improve survival in rectal cancer, 1991 • Computerized pain medication infusion pumps developed • Combination chemotherapies proven effective Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 News News Cancer Concepts: .< • Established that proto-oncogenes play roles in normal cell cycle control, 1970s • Cytochrome P450 enzyme system shown to activate many carcinogens, 1970s • Metastatic cells shown to arise from subpopulations in primary tumors, 1978 • Multistep nature of carcinogenesis proven by 1990 Prevention: • Prevalence of adult cigarette smoking dropped from 37% in 1971 to 24% in 1993 • Dietary guidelines to reduce cancer developed, 1984 • First chemoprevention trial reported showing efficacy (vitamin A analogue against mouth and throat tumors), 1990 • ASSIST, largest tobacco prevention and control project in U.S., launched, 1991 • NCI-sponsored studies in China show importance of nutrition in preventing cancer, 1991. Detection and Diagnosis: • Computed tomography introduced to the United States, 1973 • Positron emission tomography (PET) developed, mid-1970s • Flexible sigmoidoscope developed, 1980 • Magnetic resonance imaging (MRI) introduced, early 1980s • Bethesda System conference developed system for reporting Pap smear results, 1988 • Mammography Quality Standards Act passed, 1992 • Transition from film-based radiology to digital computer-assisted medical imaging • Transition from gross anatomic imaging to visualizing tissue and cell function • Transition from noninvasive imaging to image-guided biopsy and treatment Anticancer Drugs (year of FDA approval): • Doxorubicin(1974) • Cisplatin (1978) •Tamoxifen(1978) • Levamisole (1990) •Paclitaxel(1992) •Topotecan(1996) • Drug analogues developed that offer greater patient convenience and slightly less toxicity Information Transfer: • Cancer Information Service (1-800-4-CANCER) opened, 1976 • First national cancer patient education program (I Can Cope) founded, 1977 • PDQ (Physician Data Query) established, 1982 • First major DNA sequence databases established, in United States (GenBank) and Germany, 1982 • Human Gene Mapping database established, 1989 Cancer Specialists: • Certification in medical oncology (6,550 now certified) first offered, 1973 • Certification in gynecologic oncology (559 now certified) first offered, 1973 • Society for Surgical Oncology (1,600 members now) established from earlier group, 1975 • Oncology Nursing Society (24,000 members now) established, 1975 • Certification in radiation oncology (3,130 now certified), 1989 • Compiled from various sources by Hugh Mclntosh Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 Levine explained. "If for any reason the support for inquiry and funding for research in those areas is shut off prematurely or is not realized to be as important, it will retard the progress of cancer research." Freeman, noting that $2.4 billion a year— 10 times as much as in 1971 — is now being infused into the National Cancer Program — is confident that financial support will continue. "That does not seem to be a major problem at this point," he said. Clinical Research But he points to the upheaval in the country's health care system and the threat it poses to clinical research. "What we're seeing now is a great challenge to the war against cancer, if something isn't done to somehow assure that cliniDr. Harold P. Freeman c a [ research • • • & ' • money is still supplied," Freeman said. Traditionally, patients' health insurance covered much of the cost of their participation in clinical research. But as health insurers have become more competitive, particularly those in the managed care industry, they have increasingly seen clinical research and training as outside their responsibility. A new way of paying for these activities will have to be developed, experts suggest, and that mechanism will likely be some sort of government funding. NEWS 1797